25 XP   0   0   10

Syndax Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Syndax together

PenkeI guess you are interested in Syndax Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Syndax Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Syndax Pharmaceuticals Inc

I send you an email if I find something interesting about Syndax Pharmaceuticals Inc.

Quick analysis of Syndax (30 sec.)










What can you expect buying and holding a share of Syndax? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€6.13
Expected worth in 1 year
€7.08
How sure are you?
38.9%

+ What do you gain per year?

Total Gains per Share
€0.96
Return On Investment
5.1%

For what price can you sell your share?

Current Price per Share
€18.80
Expected price per share
€14.20 - €21.60
How sure are you?
50%

1. Valuation of Syndax (5 min.)




Live pricePrice per Share (EOD)

€18.80

Intrinsic Value Per Share

€-20.59 - €-24.38

Total Value Per Share

€-14.47 - €-18.26

2. Growth of Syndax (5 min.)




Is Syndax growing?

Current yearPrevious yearGrowGrow %
How rich?$554.1m$385.5m$51.7m11.8%

How much money is Syndax making?

Current yearPrevious yearGrowGrow %
Making money-$52.3m-$37.3m-$15m-28.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Syndax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#96 / 1016

Most Revenue
#622 / 1016

Most Profit
#894 / 1016

Most Efficient
#887 / 1016

What can you expect buying and holding a share of Syndax? (5 min.)

Welcome investor! Syndax's management wants to use your money to grow the business. In return you get a share of Syndax.

What can you expect buying and holding a share of Syndax?

First you should know what it really means to hold a share of Syndax. And how you can make/lose money.

Speculation

The Price per Share of Syndax is €18.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Syndax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Syndax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €6.13. Based on the TTM, the Book Value Change Per Share is €0.24 per quarter. Based on the YOY, the Book Value Change Per Share is €0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Syndax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.85-4.5%-0.62-3.3%-0.44-2.3%-0.29-1.5%-0.29-1.5%
Usd Book Value Change Per Share2.2912.2%0.261.4%0.170.9%0.361.9%0.361.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.2912.2%0.261.4%0.170.9%0.361.9%0.361.9%
Usd Price Per Share20.33-18.98-21.43-16.93-16.93-
Price to Earnings Ratio-5.96--8.07--12.23--11.70--11.70-
Price-to-Total Gains Ratio8.86--31.17--61.85--37.07--37.07-
Price to Book Ratio3.12-3.74-4.79-7.46-7.46-
Price-to-Total Gains Ratio8.86--31.17--61.85--37.07--37.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.01448
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.260.36
Usd Total Gains Per Share0.260.36
Gains per Quarter (49 shares)12.5017.75
Gains per Year (49 shares)50.0271.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10504007161
20100900142132
301501400213203
402001900284274
502502400355345
603002900426416
703503400497487
804003900568558
904504400639629
1005004900710700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%

Fundamentals of Syndax

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-18 03:12:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Syndax Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Syndax earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2,212.1%+2,212.1%
5Y-2,212.1%10Y-2,212.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y-2,212.1%-438.4%-1,773.7%
10Y-2,212.1%-605.5%-1,606.6%
1.1.2. Return on Assets

Shows how efficient Syndax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • -11.8% Return on Assets means that Syndax generated €-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Syndax Pharmaceuticals Inc:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-11.0%-0.8%
TTM-11.0%YOY-8.9%-2.0%
TTM-11.0%5Y-9.2%-1.8%
5Y-9.2%10Y-9.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-13.5%+1.7%
TTM-11.0%-12.9%+1.9%
YOY-8.9%-11.8%+2.9%
5Y-9.2%-14.1%+4.9%
10Y-9.2%-16.0%+6.8%
1.1.3. Return on Equity

Shows how efficient Syndax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • -13.1% Return on Equity means Syndax generated €-0.13 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Syndax Pharmaceuticals Inc:

  • The MRQ is -13.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.1%TTM-12.0%-1.1%
TTM-12.0%YOY-9.8%-2.2%
TTM-12.0%5Y-13.0%+1.0%
5Y-13.0%10Y-13.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.1%-16.9%+3.8%
TTM-12.0%-16.1%+4.1%
YOY-9.8%-15.1%+5.3%
5Y-13.0%-19.9%+6.9%
10Y-13.0%-20.9%+7.9%

1.2. Operating Efficiency of Syndax Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Syndax is operating .

  • Measures how much profit Syndax makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2,165.3%+2,165.3%
5Y-2,165.3%10Y-2,165.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y-2,165.3%-477.4%-1,687.9%
10Y-2,165.3%-625.6%-1,539.7%
1.2.2. Operating Ratio

Measures how efficient Syndax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y22.330-22.330
5Y22.33010Y22.3300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y22.3305.679+16.651
10Y22.3307.894+14.436

1.3. Liquidity of Syndax Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Syndax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.00 means the company has €10.00 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 9.999. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.974. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.999TTM12.974-2.976
TTM12.974YOY15.119-2.145
TTM12.9745Y12.248+0.726
5Y12.24810Y12.2480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9993.914+6.085
TTM12.9744.220+8.754
YOY15.1195.388+9.731
5Y12.2486.045+6.203
10Y12.2486.406+5.842
1.3.2. Quick Ratio

Measures if Syndax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • A Quick Ratio of 4.86 means the company can pay off €4.86 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 4.857. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.608. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.857TTM9.608-4.751
TTM9.608YOY10.870-1.262
TTM9.6085Y8.270+1.338
5Y8.27010Y8.2700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8573.572+1.285
TTM9.6083.998+5.610
YOY10.8705.390+5.480
5Y8.2705.969+2.301
10Y8.2706.287+1.983

1.4. Solvency of Syndax Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Syndax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Syndax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Syndax assets are financed with 9.6% credit (debt) and the remaining percentage (100% - 9.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 0.096. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.080. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.096TTM0.080+0.015
TTM0.080YOY0.086-0.005
TTM0.0805Y0.187-0.107
5Y0.18710Y0.1870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0960.336-0.240
TTM0.0800.334-0.254
YOY0.0860.269-0.183
5Y0.1870.366-0.179
10Y0.1870.390-0.203
1.4.2. Debt to Equity Ratio

Measures if Syndax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Syndax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.6% means that company has €0.11 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Syndax Pharmaceuticals Inc:

  • The MRQ is 0.106. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.088. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.106TTM0.088+0.018
TTM0.088YOY0.094-0.007
TTM0.0885Y0.281-0.193
5Y0.28110Y0.2810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1060.382-0.276
TTM0.0880.396-0.308
YOY0.0940.335-0.241
5Y0.2810.434-0.153
10Y0.2810.465-0.184

2. Market Valuation of Syndax Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Syndax generates.

  • Above 15 is considered overpriced but always compare Syndax to the Biotechnology industry mean.
  • A PE ratio of -5.96 means the investor is paying €-5.96 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Syndax Pharmaceuticals Inc:

  • The EOD is -5.867. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.961. Based on the earnings, the company is expensive. -2
  • The TTM is -8.073. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.867MRQ-5.961+0.094
MRQ-5.961TTM-8.073+2.112
TTM-8.073YOY-12.228+4.155
TTM-8.0735Y-11.696+3.623
5Y-11.69610Y-11.6960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.867-2.259-3.608
MRQ-5.961-2.569-3.392
TTM-8.073-2.664-5.409
YOY-12.228-4.120-8.108
5Y-11.696-6.258-5.438
10Y-11.696-6.171-5.525
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Syndax Pharmaceuticals Inc:

  • The EOD is -10.284. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.448. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.186. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.284MRQ-10.448+0.164
MRQ-10.448TTM-10.186-0.262
TTM-10.186YOY-15.056+4.870
TTM-10.1865Y-11.746+1.560
5Y-11.74610Y-11.7460.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.284-2.924-7.360
MRQ-10.448-3.246-7.202
TTM-10.186-3.488-6.698
YOY-15.056-5.620-9.436
5Y-11.746-8.315-3.431
10Y-11.746-8.826-2.920
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Syndax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.12 means the investor is paying €3.12 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Syndax Pharmaceuticals Inc:

  • The EOD is 3.069. Based on the equity, the company is fair priced.
  • The MRQ is 3.118. Based on the equity, the company is fair priced.
  • The TTM is 3.738. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.069MRQ3.118-0.049
MRQ3.118TTM3.738-0.620
TTM3.738YOY4.789-1.051
TTM3.7385Y7.461-3.724
5Y7.46110Y7.4610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0691.851+1.218
MRQ3.1182.090+1.028
TTM3.7382.095+1.643
YOY4.7892.844+1.945
5Y7.4613.466+3.995
10Y7.4613.815+3.646
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Syndax Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.1550.240+799%0.163+1220%0.340+533%0.340+533%
Book Value Per Share--6.1264.833+27%4.261+44%3.072+99%3.072+99%
Current Ratio--9.99912.974-23%15.119-34%12.248-18%12.248-18%
Debt To Asset Ratio--0.0960.080+19%0.086+12%0.187-49%0.187-49%
Debt To Equity Ratio--0.1060.088+21%0.094+12%0.281-62%0.281-62%
Dividend Per Share----0%-0%-0%-0%
Eps---0.801-0.579-28%-0.413-48%-0.269-66%-0.269-66%
Free Cash Flow Per Share---0.457-0.444-3%-0.369-19%-0.232-49%-0.232-49%
Free Cash Flow To Equity Per Share--2.4000.286+739%0.107+2151%0.361+565%0.361+565%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---24.382--------
Intrinsic Value_10Y_min---20.592--------
Intrinsic Value_1Y_max---1.191--------
Intrinsic Value_1Y_min---1.169--------
Intrinsic Value_3Y_max---4.533--------
Intrinsic Value_3Y_min---4.309--------
Intrinsic Value_5Y_max---9.026--------
Intrinsic Value_5Y_min---8.295--------
Market Cap1597618284.800-2%1623112193.6001514763081.200+7%1710216382.000-5%1351177166.400+20%1351177166.400+20%
Net Profit Margin----0%-0%-22.1210%-22.1210%
Operating Margin----0%-0%-21.6530%-21.6530%
Operating Ratio----0%-0%22.330-100%22.330-100%
Pb Ratio3.069-2%3.1183.738-17%4.789-35%7.461-58%7.461-58%
Pe Ratio-5.867+2%-5.961-8.073+35%-12.228+105%-11.696+96%-11.696+96%
Price Per Share18.800-2%19.10017.825+7%20.125-5%15.900+20%15.900+20%
Price To Free Cash Flow Ratio-10.284+2%-10.448-10.186-3%-15.056+44%-11.746+12%-11.746+12%
Price To Total Gains Ratio8.722-2%8.861-31.172+452%-61.853+798%-37.075+518%-37.075+518%
Quick Ratio--4.8579.608-49%10.870-55%8.270-41%8.270-41%
Return On Assets---0.118-0.110-7%-0.089-24%-0.092-22%-0.092-22%
Return On Equity---0.131-0.120-8%-0.098-25%-0.130-1%-0.130-1%
Total Gains Per Share--2.1550.240+799%0.163+1220%0.340+533%0.340+533%
Usd Book Value--554184239.961437222721.937+27%385501819.478+44%277886992.002+99%277886992.002+99%
Usd Book Value Change Per Share--2.2950.255+799%0.174+1220%0.362+533%0.362+533%
Usd Book Value Per Share--6.5215.145+27%4.536+44%3.270+99%3.270+99%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.853-0.616-28%-0.439-48%-0.286-66%-0.286-66%
Usd Free Cash Flow---41348122.574-40149398.012-3%-33418040.854-19%-18695936.597-55%-18695936.597-55%
Usd Free Cash Flow Per Share---0.487-0.472-3%-0.393-19%-0.248-49%-0.248-49%
Usd Free Cash Flow To Equity Per Share--2.5550.305+739%0.113+2151%0.384+565%0.384+565%
Usd Market Cap1700824425.998-2%1727965241.3071612616776.246+7%1820696360.277-5%1438463211.349+20%1438463211.349+20%
Usd Price Per Share20.014-2%20.33418.976+7%21.425-5%16.927+20%16.927+20%
Usd Profit---72471462.123-52338889.345-28%-37333707.762-48%-24097210.869-67%-24097210.869-67%
Usd Revenue----0%-0%7887832.617-100%7887832.617-100%
Usd Total Gains Per Share--2.2950.255+799%0.174+1220%0.362+533%0.362+533%
 EOD+2 -6MRQTTM+15 -14YOY+12 -175Y+17 -1410Y+17 -14

3.2. Fundamental Score

Let's check the fundamental score of Syndax Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.867
Price to Book Ratio (EOD)Between0-13.069
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.857
Current Ratio (MRQ)Greater than19.999
Debt to Asset Ratio (MRQ)Less than10.096
Debt to Equity Ratio (MRQ)Less than10.106
Return on Equity (MRQ)Greater than0.15-0.131
Return on Assets (MRQ)Greater than0.05-0.118
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Syndax Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose18.800
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets612,880
Total Liabilities58,684
Total Stockholder Equity554,196
 As reported
Total Liabilities 58,684
Total Stockholder Equity+ 554,196
Total Assets = 612,880

Assets

Total Assets612,880
Total Current Assets580,876
Long-term Assets32,004
Total Current Assets
Cash And Cash Equivalents 295,394
Short-term Investments 282,189
Other Current Assets 63
Total Current Assets  (as reported)580,876
Total Current Assets  (calculated)577,646
+/- 3,230
Long-term Assets
Property Plant Equipment 1,495
Long Term Investments 29,829
Long-term Assets Other 680
Long-term Assets  (as reported)32,004
Long-term Assets  (calculated)32,004
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities58,096
Long-term Liabilities588
Total Stockholder Equity554,196
Total Current Liabilities
Accounts payable 17,193
Other Current Liabilities 888
Total Current Liabilities  (as reported)58,096
Total Current Liabilities  (calculated)18,081
+/- 40,015
Long-term Liabilities
Long-term Liabilities  (as reported)588
Long-term Liabilities  (calculated)0
+/- 588
Total Stockholder Equity
Total Stockholder Equity (as reported)554,196
Total Stockholder Equity (calculated)0
+/- 554,196
Other
Capital Stock8
Common Stock Shares Outstanding 84,827
Net Invested Capital 554,196
Net Working Capital 522,780
Property Plant and Equipment Gross 1,906



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
76,381
63,525
105,155
192,628
179,309
300,613
279,672
263,059
239,503
449,657
422,222
406,437
359,687
497,236
459,826
431,340
399,224
612,880
612,880399,224431,340459,826497,236359,687406,437422,222449,657239,503263,059279,672300,613179,309192,628105,15563,52576,381
   > Total Current Assets 
74,850
62,331
104,206
191,807
177,432
298,864
278,947
262,555
238,252
448,396
420,056
392,287
357,631
489,786
441,511
409,080
380,974
580,876
580,876380,974409,080441,511489,786357,631392,287420,056448,396238,252262,555278,947298,864177,432191,807104,20662,33174,850
       Cash And Cash Equivalents 
30,581
24,609
44,629
53,611
56,356
115,243
64,386
68,041
71,433
221,965
188,773
120,239
71,377
74,356
57,517
97,275
94,550
295,394
295,39494,55097,27557,51774,35671,377120,239188,773221,96571,43368,04164,386115,24356,35653,61144,62924,60930,581
       Short-term Investments 
41,657
35,166
54,376
133,142
113,803
177,822
206,949
185,091
158,281
217,971
222,136
256,439
279,331
410,041
380,688
308,749
279,271
282,189
282,189279,271308,749380,688410,041279,331256,439222,136217,971158,281185,091206,949177,822113,803133,14254,37635,16641,657
       Net Receivables 
0
532
491
245
230
199
285
435
185
429
6,418
410
410
4,057
1,393
534
3,407
0
03,4075341,3934,0574104106,4184291854352851992302454915320
       Other Current Assets 
853
347
522
484
435
432
121
286
353
495
575
13,400
4,806
194
170
279
277
63
632772791701944,80613,400575495353286121432435484522347853
   > Long-term Assets 
1,531
1,194
949
821
1,877
1,749
725
504
1,251
1,261
2,166
14,150
2,056
15,965
18,315
22,260
18,250
32,004
32,00418,25022,26018,31515,9652,05614,1502,1661,2611,2515047251,7491,8778219491,1941,531
       Property Plant Equipment 
0
997
867
739
610
482
610
504
1,251
1,261
1,139
1,030
1,175
1,059
946
1,981
1,741
1,495
1,4951,7411,9819461,0591,1751,0301,1391,2611,2515046104826107398679970
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
12,125
0
5,469
16,561
19,483
15,705
29,829
29,82915,70519,48316,5615,469012,12500000000000
       Long-term Assets Other 
401
197
82
82
1,267
1,267
115
0
0
0
1,027
995
881
922
808
796
804
680
6808047968089228819951,0270001151,2671,2678282197401
> Total Liabilities 
32,338
31,925
51,646
44,981
47,332
48,425
51,467
48,496
40,499
41,289
47,673
44,497
21,585
29,787
24,321
31,299
40,038
58,684
58,68440,03831,29924,32129,78721,58544,49747,67341,28940,49948,49651,46748,42547,33244,98151,64631,92532,338
   > Total Current Liabilities 
18,294
18,368
18,790
12,467
15,157
18,872
24,568
24,292
28,712
20,683
30,551
30,925
20,803
29,065
23,721
30,168
39,174
58,096
58,09639,17430,16823,72129,06520,80330,92530,55120,68328,71224,29224,56818,87215,15712,46718,79018,36818,294
       Short Long Term Debt 
0
0
0
0
0
2,285
4,632
7,030
9,489
0
3,568
7,212
0
0
0
0
0
0
0000007,2123,56809,4897,0304,6322,28500000
       Accounts payable 
6,757
6,178
8,998
1,832
3,836
3,508
6,529
3,624
5,122
5,669
8,231
6,438
7,115
4,350
8,057
10,978
6,049
17,193
17,1936,04910,9788,0574,3507,1156,4388,2315,6695,1223,6246,5293,5083,8361,8328,9986,1786,757
       Other Current Liabilities 
263
1,517
2,052
2,227
1,987
1,517
1,714
1,809
188
187
1,893
3,166
3,186
604
703
1,027
768
888
8887681,0277036043,1863,1661,8931871881,8091,7141,5171,9872,2272,0521,517263
   > Long-term Liabilities 
14,044
13,557
32,856
32,514
32,175
29,553
26,899
24,204
11,787
20,606
17,122
13,572
782
722
600
1,131
864
588
5888641,13160072278213,57217,12220,60611,78724,20426,89929,55332,17532,51432,85613,55714,044
       Capital Lease Obligations Min Short Term Debt
1,003
897
786
667
545
417
536
419
1,167
1,072
974
879
1,257
1,161
1,059
2,099
1,870
1,635
1,6351,8702,0991,0591,1611,2578799741,0721,1674195364175456677868971,003
       Long-term Liabilities Other 
6
5
4
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
000000000000123456
> Total Stockholder Equity
44,043
31,600
53,509
147,647
131,977
252,188
228,205
214,563
199,004
408,368
374,549
361,940
338,102
467,449
435,505
400,041
359,186
554,196
554,196359,186400,041435,505467,449338,102361,940374,549408,368199,004214,563228,205252,188131,977147,64753,50931,60044,043
   Common Stock
0
3
3
4
4
5
5
5
5
6
6
6
6
7
7
7
0
0
007776666555544330
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
48
117
53
-4
9
17
11
45
-640
-1,335
-1,605
-806
-336
-574
0
0
00-574-336-806-1,605-1,335-6404511179-4531174800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-229,954
Operating Income-229,954-229,954
 
Operating Expense (+$)
Research Development163,032
Selling General Administrative66,922
Selling And Marketing Expenses-
Operating Expense229,954229,954
 
Net Interest Income (+$)
Interest Income21,163
Interest Expense-208
Other Finance Cost-0
Net Interest Income20,955
 
Pretax Income (+$)
Operating Income-229,954
Net Interest Income20,955
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-209,360-229,593
EBIT - interestExpense = -208
-209,360
-209,152
Interest Expense208
Earnings Before Interest and Taxes (EBIT)--209,152
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-209,360
Tax Provision--
Net Income From Continuing Ops-209,360-209,360
Net Income-209,360
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-361-20,955
 

Technical Analysis of Syndax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Syndax. The general trend of Syndax is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Syndax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Syndax Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 19.40 < 19.40 < 21.60.

The bearish price targets are: 17.70 > 15.70 > 14.20.

Tweet this
Syndax Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Syndax Pharmaceuticals Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Syndax Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartSyndax Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Syndax Pharmaceuticals Inc. The current adx is .

Syndax Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartSyndax Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Stochastic Oscillator ChartSyndax Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartSyndax Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartSyndax Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Williams %R ChartSyndax Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Average True Range (ATR) ChartSyndax Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartSyndax Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartSyndax Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Syndax Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Syndax Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Syndax Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose18.800
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Syndax with someone you think should read this too:
  • Are you bullish or bearish on Syndax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Syndax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Syndax Pharmaceuticals Inc

I send you an email if I find something interesting about Syndax Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Syndax Pharmaceuticals Inc.

Receive notifications about Syndax Pharmaceuticals Inc in your mailbox!